This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Cuorips Inc., Osaka University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1,044 
Years Active: 2026
Title: Yasuhiro Yanagi: Innovator in Disease-Site-Specific Treatments
Introduction
Yasuhiro Yanagi is a notable inventor based in Hyogo, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of disease-site-specific treatments. His innovative approach aims to enhance the efficacy and safety of drug delivery systems.
Latest Patents
Yasuhiro Yanagi holds a patent for a disease-site-specific liposomal formulation. This invention provides clinically applicable, safe, and convenient pharmaceutical compositions and methods for targeted treatment. The formulation comprises a stealth liposome that encapsulates a prostaglandin I2 receptor agonist, which is designed to improve therapeutic outcomes for patients.
Career Highlights
Throughout his career, Yanagi has worked with prestigious institutions, including Osaka University and Cuorips Inc. His work has focused on developing advanced drug delivery systems that can effectively target specific disease sites, thereby minimizing side effects and improving patient care.
Collaborations
One of his notable collaborators is Shigeru Miyagawa. Their partnership has contributed to the advancement of research in pharmaceutical sciences and innovative treatment methodologies.
Conclusion
Yasuhiro Yanagi's contributions to disease-site-specific treatments exemplify the importance of innovation in the pharmaceutical industry. His work continues to pave the way for safer and more effective therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile